Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited（TAK）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
tak · 股价预测 · 6 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 6 位华尔街分析师
Buy
6 位分析师
共识
评级分布
12 个月目标价
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $15.82
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $15.38 | ↓ 2.75% |
1-day model range: $15.34–$15.43. Peak: $15.43 (-2.75%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $18 | +11.9% |
| 2028 | $19 | +20.5% |
| 2029 | $20 | +26.5% |
| 2030 | $21 | +30.7% |
| 2031 | — | +33.4% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · TAK · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2023-05-16 | TD Cowen | Maintains | Outperform→Outperform |
| 2023-04-04 | TD Cowen | Maintains | Outperform→Outperform |
| 2023-03-16 | B of A Securities | Upgrade ↑ | Neutral→Buy |
| 2022-07-19 | Cowen & Co. | Upgrade ↑ | Market Perform→Outperform |
| 2021-10-07 | Morgan Stanley | Downgrade ↓ | Overweight→Equal Weight |
| 2020-03-11 | JP Morgan | Maintains | Overweight→Overweight |
| 2019-11-01 | Cowen & Co. | Maintains | Market Perform→Perform |
| 2019-09-24 | Jefferies | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Takeda Pharmaceutical Company Limited (TAK) stock. Of the recent 8 rating actions, 2 were upgrades and 1 were downgrades. 6 analysts currently cover TAK.
分析师推荐趋势
TAK analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$4.65T
↓ 3.9% YoY
Revenue Next Year
$4.72T
↑ 1.4% YoY
EPS This Year
$70.05
EPS Next Year
$99.50
↑ 42.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast TAK EPS of $70.05 for the current fiscal year, based on estimates from 2 analysts. The TAK revenue forecast is $4.65T for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
TAK 股价预测由两类独立数据源支撑：来自 6 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。TAK 的共识目标价为 $0.00（+0.0% 上行空间），分析师共识为 Buy。
TAK 的短期预测（明日）为 $15.38（-2.75%）。 TAK 对 2027 年的股价预测均值为 $18。 TAK 对 2030 年的预测区间为 $20–$21。
Takeda Pharmaceutical Company Limited 在 NYSE 上市，代码 TAK。TAK 在 2027 年的整体展望偏积极，在覆盖分析师中约 83% 对应 Buy 共识。
常见问题
TAK 预测 · 8 个问题根据 6 位华尔街分析师，TAK 的 12 个月平均目标价为 $0.00，最高 $0.00、最低 $0.00。若有图表，中位目标价可在上方查看。相对当前价 $15.82，隐含约 +0.0% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.